# Dexmedetomidine Pharmacokinetics During Continuous Renal Replacement Therapy (CRRT)

> **NCT01314209** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Helsinki University Central Hospital** · enrollment: 10 (estimated)

## Conditions studied

- Acute Kidney Injury

## Interventions

- **DRUG:** Dexmedetomidine

## Key facts

- **NCT ID:** NCT01314209
- **Lead sponsor:** Helsinki University Central Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-03
- **Primary completion:** 2014-03
- **Final completion:** —
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2012-10-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01314209

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01314209, "Dexmedetomidine Pharmacokinetics During Continuous Renal Replacement Therapy (CRRT)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01314209. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*